A citation-based method for searching scientific literature

Deepavali Chakravarti, Kyle A LaBella, Ronald A DePinho. Cell 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Origins of Bladder Cancer.
Bogdan Czerniak, Colin Dinney, David McConkey. Annu Rev Pathol 2016
76
50

Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer.
Sebastian Stasik, Karsten Salomo, Ulrike Heberling, Michael Froehner, Ulrich Sommer, Gustavo B Baretton, Gerhard Ehninger, Manfred P Wirth, Christian Thiede, Susanne Fuessel. Clin Biochem 2019
16
50

Bladder Tumor Subtype Commitment Occurs in Carcinoma In Situ Driven by Key Signaling Pathways Including ECM Remodeling.
Adrian Wullweber, Reiner Strick, Fabienne Lange, Danijel Sikic, Helge Taubert, Sven Wach, Bernd Wullich, Simone Bertz, Veronika Weyerer, Robert Stoehr,[...]. Cancer Res 2021
2
50

TERT C228T mutation in non-malignant bladder urothelium is associated with intravesical recurrence for patients with non-muscle invasive bladder cancer.
Yujiro Hayashi, Kazutoshi Fujita, Satoshi Nojima, Eisuke Tomiyama, Makoto Matsushita, Yoko Koh, Kosuke Nakano, Cong Wang, Yu Ishizuya, Taigo Kato,[...]. Mol Oncol 2020
7
50

Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.
Sumit Borah, Linghe Xi, Arthur J Zaug, Natasha M Powell, Garrett M Dancik, Scott B Cohen, James C Costello, Dan Theodorescu, Thomas R Cech. Science 2015
186
50

Pure Large Nested Variant of Urothelial Carcinoma (LNUC) Is the Prototype of an FGFR3 Mutated Aggressive Urothelial Carcinoma with Luminal-Papillary Phenotype.
Veronika Weyerer, Markus Eckstein, Eva Compérat, Hendrik Juette, Nadine T Gaisa, Yves Allory, Robert Stöhr, Bernd Wullich, Morgan Rouprêt, Arndt Hartmann,[...]. Cancers (Basel) 2020
4
50

Identification of neutral tumor evolution across cancer types.
Marc J Williams, Benjamin Werner, Chris P Barnes, Trevor A Graham, Andrea Sottoriva. Nat Genet 2016
265
50


Epidemiology and risk factors of urothelial bladder cancer.
Maximilian Burger, James W F Catto, Guido Dalbagni, H Barton Grossman, Harry Herr, Pierre Karakiewicz, Wassim Kassouf, Lambertus A Kiemeney, Carlo La Vecchia, Shahrokh Shariat,[...]. Eur Urol 2013
930
50

Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis.
Cagatay Günes, Felix Wezel, Jennifer Southgate, Christian Bolenz. Nat Rev Urol 2018
20
50

The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.
Peter A Humphrey, Holger Moch, Antonio L Cubilla, Thomas M Ulbright, Victor E Reuter. Eur Urol 2016
555
50

Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.
Yves Allory, Willemien Beukers, Ana Sagrera, Marta Flández, Miriam Marqués, Mirari Márquez, Kirstin A van der Keur, Lars Dyrskjot, Irene Lurkin, Marcel Vermeij,[...]. Eur Urol 2014
153
50

TERT promoter mutation analysis as a surrogate to morphology and immunohistochemistry in problematic spindle cell lesions of the urinary bladder.
Simone Bertz, Robert Stöhr, Nadine T Gaisa, Bernd Wullich, Arndt Hartmann, Abbas Agaimy. Histopathology 2020
2
50

Heterogeneity of telomerase reverse transcriptase mutation and expression, telomerase activity and telomere length across human cancer cell lines cultured in vitro.
Marta Dratwa, Barbara Wysoczanska, Eliza Turlej, Artur Anisiewicz, Magdalena Maciejewska, Joanna Wietrzyk, Katarzyna Bogunia-Kubik. Exp Cell Res 2020
2
50

Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapy.
Timon Heide, Angela Maurer, Monika Eipel, Katrin Knoll, Mirja Geelvink, Juergen Veeck, Ruth Knuechel, Julius van Essen, Robert Stoehr, Arndt Hartmann,[...]. J Pathol 2019
11
50

Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types.
A Kilian, D D Bowtell, H E Abud, G R Hime, D J Venter, P K Keese, E L Duncan, R R Reddel, R A Jefferson. Hum Mol Genet 1997
496
50

Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies.
Christian Hafner, Ruth Knuechel, Robert Stoehr, Arndt Hartmann. Int J Cancer 2002
122
50

Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
Jianxin Shi, Xiaohong R Yang, Bari Ballew, Melissa Rotunno, Donato Calista, Maria Concetta Fargnoli, Paola Ghiorzo, Brigitte Bressac-de Paillerets, Eduardo Nagore, Marie Francoise Avril,[...]. Nat Genet 2014
183
50

The telosome/shelterin complex and its functions.
Huawei Xin, Dan Liu, Zhou Songyang. Genome Biol 2008
119
50

Genetic and molecular identification of three human TPP1 functions in telomerase action: recruitment, activation, and homeostasis set point regulation.
Alec N Sexton, Samuel G Regalado, Christine S Lai, Gregory J Cost, Colleen M O'Neil, Fyodor D Urnov, Philip D Gregory, Rudolf Jaenisch, Kathleen Collins, Dirk Hockemeyer. Genes Dev 2014
72
50

Telomere protection by TPP1/POT1 requires tethering to TIN2.
Kaori K Takai, Tatsuya Kibe, Jill R Donigian, David Frescas, Titia de Lange. Mol Cell 2011
135
50

Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases.
Dirk Hockemeyer, Frank Soldner, Caroline Beard, Qing Gao, Maisam Mitalipova, Russell C DeKelver, George E Katibah, Ranier Amora, Elizabeth A Boydston, Bryan Zeitler,[...]. Nat Biotechnol 2009
717
50

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
50


Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis.
Thet Thet Lin, Boitelo T Letsolo, Rhiannon E Jones, Jan Rowson, Guy Pratt, Saman Hewamana, Chris Fegan, Chris Pepper, Duncan M Baird. Blood 2010
114
50

Telomere fusions associate with coding sequence and copy number alterations in CLL.
Laura Escudero, Kez Cleal, Kevin Ashelford, Chris Fegan, Chris Pepper, Kate Liddiard, Duncan M Baird. Leukemia 2019
4
50

Telomere Replication Stress Induced by POT1 Inactivation Accelerates Tumorigenesis.
Alexandra M Pinzaru, Robert A Hom, Angela Beal, Aaron F Phillips, Eric Ni, Timothy Cardozo, Nidhi Nair, Jaehyuk Choi, Deborah S Wuttke, Agnel Sfeir,[...]. Cell Rep 2016
57
50

Pot1 OB-fold mutations unleash telomere instability to initiate tumorigenesis.
P Gu, Y Wang, K K Bisht, L Wu, L Kukova, E M Smith, Y Xiao, S M Bailey, M Lei, J Nandakumar,[...]. Oncogene 2017
28
50

Structural insights into POT1-TPP1 interaction and POT1 C-terminal mutations in human cancer.
Cong Chen, Peili Gu, Jian Wu, Xianyun Chen, Shuangshuang Niu, Hong Sun, Lijie Wu, Na Li, Junhui Peng, Shaohua Shi,[...]. Nat Commun 2017
40
50

Telomerase activity in melanocytic lesions: A potential marker of tumor biology.
P Rudolph, C Schubert, S Tamm, K Heidorn, A Hauschild, I Michalska, S Majewski, G Krupp, S Jablonska, R Parwaresch. Am J Pathol 2000
59
50

Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres.
Dirk Hockemeyer, Jan-Peter Daniels, Hiroyuki Takai, Titia de Lange. Cell 2006
276
50

TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase.
Huawei Xin, Dan Liu, Ma Wan, Amin Safari, Hyeung Kim, Wen Sun, Matthew S O'Connor, Zhou Songyang. Nature 2007
350
50

Analyzing CRISPR genome-editing experiments with CRISPResso.
Luca Pinello, Matthew C Canver, Megan D Hoban, Stuart H Orkin, Donald B Kohn, Daniel E Bauer, Guo-Cheng Yuan. Nat Biotechnol 2016
198
50

Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice.
S E Artandi, S Chang, S L Lee, S Alson, G J Gottlieb, L Chin, R A DePinho. Nature 2000
828
50

Long telomeres and cancer risk among 95 568 individuals from the general population.
Line Rode, Børge G Nordestgaard, Stig E Bojesen. Int J Epidemiol 2016
51
50

Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia.
Göran Roos, Alexander Kröber, Pawel Grabowski, Dirk Kienle, Andreas Bühler, Hartmut Döhner, Richard Rosenquist, Stephan Stilgenbauer. Blood 2008
97
50

A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.
Helen E Speedy, Maria Chiara Di Bernardo, Georgina P Sava, Martin J S Dyer, Amy Holroyd, Yufei Wang, Nicola J Sunter, Larry Mansouri, Gunnar Juliusson, Karin E Smedby,[...]. Nat Genet 2014
113
50

Structural and functional analysis of the human POT1-TPP1 telomeric complex.
Cory Rice, Prashanth Krishna Shastrula, Andrew V Kossenkov, Robert Hills, Duncan M Baird, Louise C Showe, Tzanko Doukov, Susan Janicki, Emmanuel Skordalakes. Nat Commun 2017
44
50

TINF2 is a haploinsufficient tumor suppressor that limits telomere length.
Isabelle Schmutz, Arjen R Mensenkamp, Kaori K Takai, Maaike Haadsma, Liesbeth Spruijt, Richarda M de Voer, Seunga Sara Choo, Franziska K Lorbeer, Emma J van Grinsven, Dirk Hockemeyer,[...]. Elife 2020
2
50

Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse.
R A Greenberg, L Chin, A Femino, K H Lee, G J Gottlieb, R H Singer, C W Greider, R A DePinho. Cell 1999
307
50

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.
Frank Soldner, Dirk Hockemeyer, Caroline Beard, Qing Gao, George W Bell, Elizabeth G Cook, Gunnar Hargus, Alexandra Blak, Oliver Cooper, Maisam Mitalipova,[...]. Cell 2009
50

The POT1-TPP1 telomere complex is a telomerase processivity factor.
Feng Wang, Elaine R Podell, Arthur J Zaug, Yuting Yang, Paul Baciu, Thomas R Cech, Ming Lei. Nature 2007
452
50

Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia.
D Rossi, C Lobetti Bodoni, E Genuardi, L Monitillo, D Drandi, M Cerri, C Deambrogi, I Ricca, A Rocci, S Ferrero,[...]. Leukemia 2009
74
50

POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end.
Dirk Hockemeyer, Agnel J Sfeir, Jerry W Shay, Woodring E Wright, Titia de Lange. EMBO J 2005
213
50

Telomeres in cancer: tumour suppression and genome instability.
John Maciejowski, Titia de Lange. Nat Rev Mol Cell Biol 2017
242
50

Expression of TERT in early premalignant lesions and a subset of cells in normal tissues.
K A Kolquist, L W Ellisen, C M Counter, M Meyerson, L K Tan, R A Weinberg, D A Haber, W L Gerald. Nat Genet 1998
345
50

The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity.
Jayakrishnan Nandakumar, Caitlin F Bell, Ina Weidenfeld, Arthur J Zaug, Leslie A Leinwand, Thomas R Cech. Nature 2012
197
50

Hypervariable ultra-long telomeres in mice.
D Kipling, H J Cooke. Nature 1990
479
50

Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations.
Rajendra N Damle, Franak M Batliwalla, Fabio Ghiotto, Angelo Valetto, Emilia Albesiano, Cristina Sison, Steven L Allen, Jonathan Kolitz, Vincent P Vinciguerra, Prasad Kudalkar,[...]. Blood 2004
130
50

Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells.
Mark A DeWitt, Wendy Magis, Nicolas L Bray, Tianjiao Wang, Jennifer R Berman, Fabrizia Urbinati, Seok-Jin Heo, Therese Mitros, Denise P Muñoz, Dario Boffelli,[...]. Sci Transl Med 2016
222
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.